Homeo AI Blog · 2026-07-22

Homeo AI vs RadarOpus: 14-day trial checklist

Compare Homeo AI and RadarOpus for using a short trial to make an evidence-based buying decision. Review product fit, evidence, workflow limits, and a…

Quick answer

RadarOpus and Homeo AI solve overlapping problems, but not in the same order. RadarOpus is a long-running professional suite centered on the Synthesis repertory, a large homeopathic library, analysis modules, patient files, and practice-management tools. Homeo AI gives priority to the patient's narrative, an editable repertory path, and a connected record across visits. That difference matters when the comparison is about using a short trial to make an evidence-based buying decision, because workflow fit is often more important than the longest feature list.

What should a practitioner test before familiarity and sunk cost influence the purchase? The most informative moment is often the first correction. For using a short trial to make an evidence-based buying decision, watch how quickly the practitioner can spot a bad assumption, return to the source, and repair the downstream record.

What RadarOpus offers

The competitor facts below were checked against RadarOpus official product overview and RadarOpus packages on 2026-07-22. They describe the public product, not an independent clinical validation.

  • RadarOpus presents Synthesis as its defining repertory and supports source-linked repertory research.
  • Its official site lists more than 80 repertories and more than 1,600 materia medica or related documents in its broader library.
  • The suite includes case analysis, practice management, search, expert systems, and privacy modules.
  • RadarOpus advertises a free AI module and separate mobile access through Opus Go.

RadarOpus may solve a large portion of the buyer's problem or only one part of it. That depends on the clinic. Separate library depth, AI assistance, records, mobile access, and practice operations before assigning a single score to the whole product.

What this comparison is really testing

A trial should answer a small set of operational questions. Browsing features without running known cases produces confidence but little evidence.

One pair-specific checkpoint is worth writing down before the trial: Patient records and practice functions can live beside the repertory workflow. The corresponding risk is this: Package choices, add-ons, and training can make the buying decision more involved. A useful test must be able to prove or disprove both statements with the same case.

Where RadarOpus may fit better

  • The library is deep enough for extensive repertory and materia medica research.
  • Synthesis source information is useful when a practitioner wants to inspect an addition.
  • Several analysis systems support different schools and methods.
  • Patient records and practice functions can live beside the repertory workflow.

These are real reasons to choose RadarOpus. A clinic that already works comfortably inside its method, library, or general productivity ecosystem may gain little from replacing that part of the workflow. Homeo AI can also be used beside another repertory or research tool when the main need is note structuring and follow-up continuity.

Where the fit needs closer testing

  • Package choices, add-ons, and training can make the buying decision more involved.
  • A deep desktop suite may require more setup than a focused browser copilot.
  • The AI module should be tested separately from the established library and analysis features.
  • Mobile repertorisation is a related product rather than the same interface on every device.

None of these points proves that RadarOpus is unsuitable. They identify the parts of the purchase that a homepage cannot settle. Ask the vendor, read the current terms, and test the exact edition or account you plan to use.

How Homeo AI approaches the same job

Homeo AI puts natural-language case notes and a guided copilot at the front of the workflow. It is designed to reduce translation and documentation work before the doctor checks rubrics and source passages. A clinic should verify this with its own cases, especially when using a short trial to make an evidence-based buying decision depends on a preferred repertory, language, or documentation rule.

The most revealing action in this comparison is: Define pass or fail criteria. Record what the product shows before and after that action. A genuine evidence trail should change in a way the practitioner can understand.

A practical head-to-head test

Use completed, de-identified cases whose reasoning and outcomes you already understand. Run the same material through both products without rewriting it to suit either interface.

  • Select three completed cases
  • Define pass or fail criteria
  • Record time and corrections
  • Export results before the trial ends

Write down time spent, material corrections, source gaps, and export quality. Repeat the test with a different case type and a second reviewer. This matters because familiarity with one interface can look like product quality during the first session.

Decision for a practitioner

The decision is not a universal ranking. RadarOpus is the better fit for experienced practitioners and researchers who place high value on Synthesis and a very large reference library. Homeo AI is the better fit when a practitioner wants a focused note-to-rubric copilot with source review and longitudinal case context. Buy only after the trial shows repeatable time savings and acceptable correction, source, privacy, and export behavior.

Price and product features can change, so confirm them on the official sources linked below. Use completed, de-identified cases until your clinic has approved privacy, access, retention, and consent procedures. Neither product should make an emergency-care decision or replace the practitioner's responsibility for diagnosis, referral, prescription, potency, dosage, and follow-up.

Official sources checked

Product facts reviewed 2026-07-22. Confirm current features, prices, source libraries, and terms with the vendor.